MAIA Biotechnology, Inc. (AMEX: MAIA) is a Healthcare company (Biotechnology) with a market capitalization of $76M. The Maz Rating grades it against the other companies in its sector.
MAIA Biotechnology, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $1.23, MAIA Biotechnology, Inc. trades at 4.2x book value. It runs a gross margin of 0.0%, an operating margin of 0.0% and a net margin of 0.0%. It shows return on equity of -153.4%, return on invested capital of -176.7% and a free cash flow yield of -40.7%. On the balance sheet: a debt-to-equity ratio of 0.00 and a current ratio of 3.41. Over the past 52 weeks the share price ranged from $0.87 to $3.19, with a beta of 0.30.
MAIA Biotechnology, Inc. does not currently pay a dividend.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.